Related Experiment Video
Updated: Aug 30, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Nitric oxide involvement in depression during interferon-alpha therapy
Eiji Suzuki1, Yoshiko Yoshida, Akitaka Shibuya
1Department of Psychiatry, Kitasato University School of Medicine, 2-1-1 Asamizodai, Sagamihara, Kanagawa, 228-8520, Japan. e-suzuki@kitasato-u.ac.jp
Abstract:
It has been postulated that interferon induces depression via a nitric oxide-related system. The purpose of this study was to test whether there was a difference in the effects of interferon-alpha (IFN-alpha) on nitric oxide production between patients with and without interferon-induced depression. The subjects had chronic hepatitis C and were being treated with IFN-alpha. We measured plasma nitrate, a marker of nitric oxide production in vivo, before, during, and after interferon therapy. Of 146 patients, 9 developed depression within the first 4 wk of interferon therapy, and 8 developed depression later. In the former group, a significant plasma nitrate increase was observed during therapy, followed by a decrease to baseline after discontinuation. This, however, was not the case with the latter group or those who had no psychiatric symptoms. These results suggest nitric oxide involvement in at least some forms of IFN-alpha-induced depression.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Antidepressant Drugs: MAOIs and Other Agents
Nitric Oxide Signaling Pathway
G Protein-coupled Receptors
Antidepressant Drugs: Overview
